Inflammasomes as mediators of inflammation in HIV-1 infection.


Journal

Translational research : the journal of laboratory and clinical medicine
ISSN: 1878-1810
Titre abrégé: Transl Res
Pays: United States
ID NLM: 101280339

Informations de publication

Date de publication:
02 2023
Historique:
received: 02 06 2022
revised: 23 07 2022
accepted: 27 07 2022
pmc-release: 01 02 2024
pubmed: 3 8 2022
medline: 14 1 2023
entrez: 2 8 2022
Statut: ppublish

Résumé

Human immunodeficiency virus type 1 (HIV-1) infection is a chronic disease without a known cure. The advent of effective antiretroviral therapy (ART) has enabled people with HIV (PWH) to have significantly prolonged life expectancies. As a result, morbidity and mortality associated with HIV-1 infection have declined considerably. However, these individuals experience chronic systemic inflammation whose multifaceted etiology is associated with other numerous comorbidities. Inflammasomes are vital mediators that contribute to inflammatory signaling in HIV-1 infection. Here, we provide an overview of the inflammatory pathway that underlies HIV-1 infection, explicitly highlighting the role of the NLRP3 inflammasome. We also delineate the current literature on inflammasomes and the therapeutic targeting strategies aimed at the NLRP3 inflammasome to moderate HIV-1 infection-associated inflammation. Here we describe the NLRP3 inflammasome as a key pathway in developing novel therapeutic targets to block HIV-1 replication and HIV-1-associated inflammatory signaling. Controlling the inflammatory pathways is critical in alleviating the morbidities and mortality associated with chronic HIV-1 infection in PWH.

Identifiants

pubmed: 35917903
pii: S1931-5244(22)00173-6
doi: 10.1016/j.trsl.2022.07.008
pmc: PMC10160852
mid: NIHMS1895879
pii:
doi:

Substances chimiques

Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
Inflammation Mediators 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI120806
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA052255
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA054526
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI152833
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Nat Immunol. 2009 Mar;10(3):241-7
pubmed: 19221555
PLoS Pathog. 2020 Aug 6;16(8):e1008752
pubmed: 32760121
Transfus Med Hemother. 2016 May;43(3):203-22
pubmed: 27403093
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
AIDS. 2019 Dec 1;33(15):2273-2288
pubmed: 31764093
Curr Opin HIV AIDS. 2008 May;3(3):356-61
pubmed: 19372990
Immunol Rev. 2009 Jan;227(1):106-28
pubmed: 19120480
J Leukoc Biol. 2013 Sep;94(3):399-407
pubmed: 23456773
Eur J Heart Fail. 2010 Apr;12(4):319-22
pubmed: 20335350
Viruses. 2022 Mar 23;14(4):
pubmed: 35458396
Biochem Pharmacol. 2013 May 15;85(10):1504-12
pubmed: 23506741
Top Antivir Med. 2012 Aug-Sep;20(3):101-5
pubmed: 22954610
New Microbiol. 2021 Apr;44(2):95-103
pubmed: 33978194
PLoS One. 2018 Apr 19;13(4):e0192845
pubmed: 29672590
Front Immunol. 2018 Feb 12;9:214
pubmed: 29483915
J Gerontol A Biol Sci Med Sci. 2007 Nov;62(11):1279-86
pubmed: 18000149
J Infect Dis. 2016 Oct 1;214 Suppl 2:S44-50
pubmed: 27625430
Front Genet. 2021 Sep 16;12:756471
pubmed: 34603402
Handb Clin Neurol. 2018;152:229-264
pubmed: 29604980
Int Rev Cell Mol Biol. 2019;345:225-285
pubmed: 30904194
J Virol. 2015 Nov 11;90(2):1080-7
pubmed: 26559826
Prescrire Int. 2004 Aug;13(72):144-50
pubmed: 15532140
J Exp Med. 2004 Jan 19;199(2):283-93
pubmed: 14734528
PLoS One. 2012;7(3):e33961
pubmed: 22448282
Cell Mol Life Sci. 2016 Jun;73(11-12):2349-67
pubmed: 27066895
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):241-9
pubmed: 19194320
Basic Res Cardiol. 2017 Dec 09;113(1):5
pubmed: 29224086
Front Immunol. 2019 Mar 18;10:465
pubmed: 30967860
J Neuroimmune Pharmacol. 2013 Sep;8(4):998-1009
pubmed: 23686368
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):256-63
pubmed: 25469528
Cell Host Microbe. 2015 Oct 14;18(4):463-70
pubmed: 26468749
Science. 1983 May 20;220(4599):868-71
pubmed: 6189183
Front Immunol. 2021 Mar 19;12:657679
pubmed: 33815419
Immunol Rev. 2013 Jul;254(1):326-42
pubmed: 23772629
Curr HIV/AIDS Rep. 2021 Jun;18(3):198-210
pubmed: 33709322
PLoS Pathog. 2017 Feb 27;13(2):e1006202
pubmed: 28241080
Cell Host Microbe. 2019 Jun 12;25(6):858-872.e13
pubmed: 31175045
Cold Spring Harb Perspect Biol. 2014 Oct 16;6(12):a016287
pubmed: 25324215
Clin Infect Dis. 2020 Aug 14;71(4):924-932
pubmed: 31751447
Molecules. 2020 Oct 07;25(19):
pubmed: 33036374
Eur J Immunol. 2015 Oct;45(10):2911-7
pubmed: 26174085
Cell Host Microbe. 2016 Mar 9;19(3):280-91
pubmed: 26962940
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
J Leukoc Biol. 2013 Sep;94(3):390-2
pubmed: 23990659
Viruses. 2020 Mar 07;12(3):
pubmed: 32155980
Cell Death Dis. 2019 Feb 12;10(2):128
pubmed: 30755589
Mol Immunol. 2022 Aug;148:68-80
pubmed: 35659727
J Immunol. 2010 Jul 15;185(2):974-81
pubmed: 20574004
J Virol. 2020 Feb 28;94(6):
pubmed: 31852781
Int J Physiol Pathophysiol Pharmacol. 2017 Dec 25;9(6):165-177
pubmed: 29348793
J Neuroinflammation. 2017 Jul 19;14(1):138
pubmed: 28724382
JAMA Netw Open. 2020 Jun 1;3(6):e208023
pubmed: 32539147
Curr HIV/AIDS Rep. 2010 May;7(2):69-76
pubmed: 20425560
PLoS One. 2016 Sep 09;11(9):e0155076
pubmed: 27611972
mBio. 2021 Dec 21;12(6):e0281721
pubmed: 34844429
Nat Rev Neurosci. 2014 Feb;15(2):84-97
pubmed: 24399084
AIDS. 2010 Oct 23;24(16):2451-60
pubmed: 20827162
Nat Med. 2015 Mar;21(3):248-55
pubmed: 25686105
Front Pharmacol. 2015 Nov 05;6:262
pubmed: 26594174
AIDS Care. 2009 May;21(5):655-63
pubmed: 19444675
Intervirology. 2014;57(1):36-42
pubmed: 24008203
Int J Immunogenet. 2014 Dec;41(6):518-20
pubmed: 25363454
J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):121-5
pubmed: 22227487
J Infect Dis. 2011 Oct 15;204(8):1217-26
pubmed: 21917895
J Exp Med. 2011 Aug 29;208(9):1823-34
pubmed: 21859844
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039
pubmed: 22315717
Cell. 2010 Nov 24;143(5):789-801
pubmed: 21111238
J Exp Med. 2004 Sep 20;200(6):749-59
pubmed: 15365096
J Neuroimmune Pharmacol. 2017 Jun;12(2):233-248
pubmed: 27726055
Front Immunol. 2015 Nov 26;6:585
pubmed: 26635799
Inflammation. 2019 Jun;42(3):904-914
pubmed: 30554372
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
PLoS Pathog. 2021 Apr 16;17(4):e1009417
pubmed: 33861800
PLoS Pathog. 2016 Jul 14;12(7):e1005761
pubmed: 27415008
Front Cell Neurosci. 2017 Mar 09;11:63
pubmed: 28337127
J Cell Biol. 2009 Oct 5;187(1):61-70
pubmed: 19805629
Viruses. 2020 Apr 29;12(5):
pubmed: 32365692
Cell Rep. 2015 Sep 8;12(10):1555-1563
pubmed: 26321639
PLoS Pathog. 2016 Dec 7;12(12):e1006048
pubmed: 27926931
J Virol. 2015 Sep;89(18):9368-82
pubmed: 26136569
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):E4571-80
pubmed: 24154727
Front Immunol. 2019 Oct 25;10:2538
pubmed: 31749805
Neurosci Lett. 2021 May 29;754:135863
pubmed: 33794296
Front Cardiovasc Med. 2020 Jun 11;7:95
pubmed: 32596261
J Biol Chem. 2014 Jan 10;289(2):1142-50
pubmed: 24265316
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):147-51
pubmed: 23507658
Annu Rev Immunol. 2000;18:665-708
pubmed: 10837072
Curr Opin HIV AIDS. 2016 Mar;11(2):234-41
pubmed: 26575148
BMJ. 2009 Jan 26;338:a3172
pubmed: 19171560
Am J Cardiol. 2013 May 15;111(10):1394-400
pubmed: 23453459
J Immunol. 2012 May 1;188(9):4488-95
pubmed: 22450808
EBioMedicine. 2018 Apr;30:192-202
pubmed: 29650491
Cell Mol Life Sci. 2016 Dec;73(23):4449-4470
pubmed: 27402121
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Annu Rev Med. 2011;62:141-55
pubmed: 21090961
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
J Infect Dis. 2014 Oct 15;210(8):1228-38
pubmed: 24755434
Trends Mol Med. 2019 Nov;25(11):941-954
pubmed: 31300343
J Infect Dis. 2010 Jun 15;201(12):1788-95
pubmed: 20446848
Vaccines (Basel). 2021 Aug 05;9(8):
pubmed: 34451992
Blood. 2004 Jul 15;104(2):487-94
pubmed: 15059848
Clin Infect Dis. 2017 Jan 15;64(2):124-131
pubmed: 27737952
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
J Neuroimmune Pharmacol. 2014 Mar;9(2):233-44
pubmed: 24158495
Nat Commun. 2018 Jun 29;9(1):2550
pubmed: 29959312
Cell Discov. 2020 Jun 9;6:36
pubmed: 32550001
Nat Immunol. 2006 Mar;7(3):235-9
pubmed: 16482171
Nature. 2014 Jan 23;505(7484):509-14
pubmed: 24356306
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Clin Exp Immunol. 2014 Jul;177(1):295-309
pubmed: 24593816
J Virol. 2014 Oct;88(19):11504-15
pubmed: 25031337
Front Immunol. 2019 Jun 11;10:1291
pubmed: 31244842
Vaccines (Basel). 2013 Sep 25;1(4):415-43
pubmed: 26344341
Drugs. 2016 Apr;76(5):533-49
pubmed: 26915027
Sci Rep. 2016 Jun 20;6:27864
pubmed: 27321752
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Clin Immunol. 2006 Aug;120(2):163-70
pubmed: 16765088
Front Physiol. 2016 Nov 24;7:559
pubmed: 27932991
Clin Infect Dis. 2012 Jul;55(1):126-36
pubmed: 22534147
AIDS Res Ther. 2014 Oct 07;11(1):33
pubmed: 25320633
Cells. 2020 Jan 20;9(1):
pubmed: 31968566
J Exp Med. 2017 Nov 6;214(11):3219-3238
pubmed: 29021150
STAR Protoc. 2020 Dec 19;2(1):100236
pubmed: 33364624
Science. 2014 Jan 24;343(6169):428-32
pubmed: 24356113
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1530-E1539
pubmed: 29378952
J Infect Dis. 2003 May 15;187(10):1534-43
pubmed: 12721933
EMBO Mol Med. 2018 Apr;10(4):
pubmed: 29531021
Lancet. 2008 Jul 26;372(9635):293-9
pubmed: 18657708
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):E4671-80
pubmed: 27462105
Cells. 2020 Aug 08;9(8):
pubmed: 32784383
J Pharmacol Exp Ther. 2010 Apr;333(1):319-27
pubmed: 20089805
J Leukoc Biol. 2018 Jan 26;:
pubmed: 29377242
HIV Med. 2013 Oct;14(9):530-9
pubmed: 23683266
Viruses. 2022 May 28;14(6):
pubmed: 35746649
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9403-8
pubmed: 19470482
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3265-73
pubmed: 26056317
Trends Mol Med. 2022 May;28(5):421-434
pubmed: 35341684
Assay Drug Dev Technol. 2015 Apr;13(3):155-66
pubmed: 25871547
Science. 2021 Jan 29;371(6528):
pubmed: 33243852
Int J Mol Sci. 2019 Jul 06;20(13):
pubmed: 31284572
J Immunol Res. 2021 Sep 20;2021:1487287
pubmed: 34595244
AIDS. 2010 Apr 24;24(7):959-68
pubmed: 20177358
PLoS One. 2015 Mar 16;10(3):e0119568
pubmed: 25775475
J Immunol. 2015 Apr 15;194(8):3873-82
pubmed: 25780040
Front Immunol. 2019 Aug 09;10:1896
pubmed: 31447862
J Neurosci. 2017 Mar 29;37(13):3599-3609
pubmed: 28270571
Curr HIV Res. 2011 Apr;9(3):148-53
pubmed: 21457131
Science. 2021 Mar 19;371(6535):
pubmed: 33542150
J Clin Invest. 2005 Aug;115(8):2047-58
pubmed: 16075046
Microbiol Mol Biol Rev. 2021 Jan 13;85(1):
pubmed: 33441488
Adv Exp Med Biol. 2019;1162:1-12
pubmed: 31332731
Cold Spring Harb Perspect Biol. 2020 May 1;12(5):
pubmed: 31570336
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Retrovirology. 2014 May 13;11:35
pubmed: 24886384
Clin Chim Acta. 2013 Feb 1;416:96-9
pubmed: 23228847
Gut. 2020 Jan;69(1):191-193
pubmed: 30518529
Curr HIV/AIDS Rep. 2010 Feb;7(1):4-10
pubmed: 20425052
Cell. 2016 May 5;165(4):792-800
pubmed: 27153493
J Exp Med. 2004 Sep 20;200(6):761-70
pubmed: 15365095
Immunity. 2008 Mar;28(3):285-7
pubmed: 18341998
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):129-34
pubmed: 23018379
Front Immunol. 2021 Jul 21;12:695674
pubmed: 34367156
J Virol. 2018 Dec 10;93(1):
pubmed: 30305360

Auteurs

Alice K Min (AK)

Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Trinisia Fortune (T)

Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Natalia Rodriguez (N)

Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Esha Hedge (E)

University of South Carolina, Columbia, South Carolina.

Talia H Swartz (TH)

Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: talia.swartz@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH